Loading clinical trials...
Loading clinical trials...
A 16 Week Randomized, Single-masked, Multicenter Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia in Children 4-7 Years of Age With an Open-label Substudy of Binocular Videogames in Children 8-12 Years of Age
The purpose of this PoC study was to evaluate the potential therapeutic efficacy of binocular video games played on a tablet and to compare the efficacy of binocular video games versus patching in amblyopic patients 4 to 7 years old (Part A) as well as to gain experience with binocular video games in older children population of 8 to12 years old (Part B). Part A and Part B was designed to provide long term data on durability of binocular video games treatment. The study consisted of two parts, Part A: randomized, single masked PoC study in children 4 to 7 years old at Screening, and Part B: open-label substudy in children 8 to 12 year old at Screening.
The clinical investigation consisted of 2 parts: * Part A: a single-masked, randomized clinical investigation in subjects 4 to 7 years of age. * Part B: an open-label, non-randomized sub-investigation in subjects 8 to 12 years of age. Part A was a 16-week, prospective, randomized, single-masked, multicenter, controlled, 2 arm, parallel-group clinical investigation in subjects 4 to 7 years of age with amblyopia. Subjects were randomly assigned in a 1:1 ratio to either binocular videogame treatment for 8 to 12 weeks or patching treatment for 16 weeks. Randomization was stratified by severity of amblyopia in eligible subjects (moderate amblyopia with best-corrected visual acuity (BCVA) of the amblyopic eye of 20/100 or better, or severe amblyopia with BCVA of the amblyopic eye worse than 20/100). Part B was a 16-week, open-label, single arm sub investigation in subjects 8 to 12 years of age with amblyopia, in which selected sites could participate. Subjects received binocular videogame treatment for 8 weeks, followed by 8 weeks of follow-up.
Age
4 - 12 years
Sex
ALL
Healthy Volunteers
No
Novartis Investigative Site
Gainesville, Florida, United States
Novartis Investigative Site
Maitland, Florida, United States
Novartis Investigative Site
Chicago, Illinois, United States
Novartis Investigative Site
Frederick, Maryland, United States
Novartis Investigative Site
Las Vegas, Nevada, United States
Novartis Investigative Site
North Ryde, New South Wales, Australia
Novartis Investigative Site
Kitchener, Ontario, Canada
Novartis Investigative Site
Waterloo, Ontario, Canada
Start Date
June 30, 2021
Primary Completion Date
August 3, 2022
Completion Date
August 3, 2022
Last Updated
May 23, 2023
27
ACTUAL participants
Binocular video games
DEVICE
Patching of the sound eye
DEVICE
Lead Sponsor
Novartis Pharmaceuticals
NCT07417046
NCT06380517
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04378790